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Abstract. Decision support is a probabilistic and quantitative method designed 
for modeling problems in situations with ambiguity. Computer technology can 
be employed to provide clinical decision support and treatment recommenda-
tions. The problem of natural language applications is that they lack formality 
and the interpretation is not consistent. Conversely, ontologies can capture the 
intended meaning and specify modeling primitives. Disease Ontology (DO) that 
pertains to cancer’s clinical stages and their corresponding information compo-
nents is utilized to improve the reasoning ability of a decision support system 
(DSS). The proposed DSS uses Case-Based Reasoning (CBR) to consider dis-
ease manifestations and provides physicians with treatment solutions from simi-
lar previous cases for reference. The proposed DSS supports natural language 
processing (NLP) queries. The DSS obtained 84.63% accuracy in disease clas-
sification with the help of the ontology. 
Keywords: Clinical decision support · Data mining · Ontology construc-
tion · Decision Support system · Case-Based Reasoning. 
1 Introduction 
Clinicians cannot obtain knowledge regarding clinical processes from the existing, 
inadequate medical databases. In current decision support systems (DSSs) [1][2], 
databases and computer records work together to facilitate decision-making by im-
proving access to relevant data through defined interfaces. We focus on researching 
the problem of classification and diagnosis. After investigating the uncertainty about 
the actual situation of the study object (patient, organ, population), it is necessary to 
distinguish the possible symptoms and diseases from the impossible ones to determine 
effective measures [3]. 
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This study proposes an ontology-based DSS to aid in cancer diagnosis and therapy. 
Several existing ontologies and high-quality data resources are available for use, in-
cluding the Disease Ontology (DO) [4], the NCBI organismal classification ontology 
(NCBI Taxonomy) [5], the Human Phenotype Ontology (HPO) [6], and DrugBank 
[7], as well as some useful websites such as the U.S. National Library of Medicine 
(NLM) [8] and Wikipedia [9]. We utilize ontology triples to improve the reasoning 
ability of the DSS. Afterwards, Case-Based Reasoning (CBR) is employed to provide 
physicians with treatment solutions from similar previous cases for reference. A case 
study concerning the answering of clinical queries about gastric cancer (diagnosis, 
prognosis and treatment) is developed to illustrate the implementation of DSS with an 
ontology. 
The main contributions of this work can be summed as followed: 
- Base the medical reasoning framework which defines rules and interfaces, 
the combined operation of DSS, CBR and ontology can aide clinical deci-
sion-making. 
- To simplify the semantic representation of medicines, existing biomedical 
ontology is reused in DSS. 
- The comparison between DSS with or without ontology presents that our 
model can fully utilize the ontology information and provides a stable per-
formance in diagnosis and disease classification. 
The rest of this paper is structured as follows: Section 2 describes the related work. 
Section 3 introduces the details of the proposed methods; Experimental results and 
evaluations are presented in Section 4. Finally, we conclude the paper in section 5. 
2 Related work 
The application of DSS for the cooperation of ontology has been investigated in many 
works shown below. Farion et al. [10] used ontology-driven design to represent com-
ponents of a CDSS. A prototype of the system was implemented for two clinical deci-
sion problems and settings (triage of acute pain in the emergency department and 
postoperative management of radical prostatectomy on the hospital ward). Haghighi 
et al. [11] have designed a knowledge acquisition tool to facilitate the creation and 
maintenance of a knowledge base by the domain expert and its sharing and reuse by 
other institutions. They used the Unified Medical Language System (UMLS) which 
contains the domain entities and constitutes the relations repository. Lee et al. [12] 
presented a novel fuzzy expert system for diabetes decision support application. The 
proposed fuzzy expert system can work effectively for diabetes decision support ap-
plication. Jayaraman et al. [13] realized the drug side effects data representation and 
full spectrum inference using ontology in Intelligent Telehealth. The proposed model 
allows the doctors and caregivers to derive dynamic information about side effects 
avoiding costly errors caused by human interpretation. Ontology is used to prevent 
electronic health record error approach [14] etc. Besides, ontology can be used in 
other domain for decision supports. Ontology is adopted to control the intercrossed 
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access for secure financial services on multimedia big data in cloud systems [15], and 
to classify cyber incident for cybersecurity insurance in financial industry [16] 
In the development of a DSS for medical decision-making, an approach using a 
quantitative model analysis has increasingly gained attention. Some tools, technolo-
gies and concepts, such as decision trees and Bayes [17] and probability theories, can 
improve the operation of medical decision-making. CBR computes component simi-
larities by exploring indexed knowledge. CBR is a qualitative and quantitative mixed 
model of experience storage and retrieval. This method is analogous to problem-
solving methods that compare new cases with previously indexed cases [18]. CBR 
involves semantic distances developed using different approaches, including algo-
rithms of structural similarity, statistical learning, digital approaches from neural net-
works, and fuzzy logic. The research on semantic distances often combines symbolic 
and numeric aspects [19]. 
3 Methods 
3.1 Architecture of DSS 
The architecture of DSS is presented in Fig. 1 and consists of the knowledge acquisi-
tion model, the ontology model and the interconnection model. Each part can be con-
sidered as an independent computing environment. The knowledge acquisition mod-
ule provides medical data to the “Interpreter module” and the “Inference engine”. The 
DSS repository recognizes, processes and stores medical data. The “Interpreter mod-
ule” operates as an algorithm controller to perform query analysis and knowledge 
extraction. The “Inference engine” mainly normalizes the interrogation flow and for-
mulates the relationships among the diagnosis, prognosis and treatment. It uses a 
case-based inference rule to analyze the likelihood and symptoms of complications of 
the current diseases so that medical care personnel can determine a prognosis or im-
plement preventive measures. 
 
Fig. 1. Architecture of DSS 
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3.2 Medical Reasoning Framework 
Based on our previous work [3], Fig. 2 presents the relations between diagnosis (Δ), 
prognosis (Π), and treatment (Θ) and describes a series of medical inference rules 
using a simulated treatment approach.  
 
Fig. 2. Reasoning between diagnosis, prognosis and treatment 
CBR successively stores and indexes clinical cases and knowledge in different direc-
tories (Δ, Π, Θ, SΘ) by identifying keywords related to the problem of the case (PB), 
the environment (patient record) (E) and the result (R). (Fig.3) 
 
Fig. 3.  Case-base reasoning 
The supervisor monitors and triggers all necessary steps of the clinical decision pro-
cess through finite state automaton (FSA) and ensures the dialogue between the com-
puter and the end-user. It controls the management and execution of clinical tasks 
with predefined available models. A model is instructed to give up a task if the situa-
tion or the operating environment is amended. 
In the DSS, each model uses reflexive knowledge to determine whether it should 
contribute to the task requested by the supervisor. If the model determines that it 
should contribute, then the supervisor assigns its part of the on-going actions, and the 
necessary models become active. Answers are extracted from the DSS repository and 
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the CBR database and listed for query answering through a matching approach by 
consulting the indexed corpus. 
3.3 Ontology Utilization 
In the DO, each ontology triple is established based on an inference rule. The DO 
triple is extracted and utilized in this study to clarify the medical knowledge and im-
prove the reasoning ability of the DSS. For example, the triple (radical surgery, cure, 
cancer) refers to the possibility that radical surgery can help to cure cancer. By means 
of inheritance and matching, the cancer-relevant knowledge contains the following 
information. 
1. Symptoms of each type of cancer. 
2. Classification, biological feautres and cell proliferation dynamics of cancer. 
3. Cancer therapies: surgical treatment (radical surgery, palliative surgery, surgical 
exploration), radiotherapy, chemotherapy (systemic chemotherapy, adjuvant 
chemotherapy, neoadjuvant chemotherapy, special approach chemotherapy for 
advanced stage or disseminated tumors) and food therapy. 
4. Basic therapeutic principles for tumors, including therapeutic regimens for head 
and neck neoplasms, thoracic neoplasms, abdominal malignant tumors, tumors 
of the urinary system, tumors of the female genital system, CNS tumors, malig-
nant tumors of the hematopoietic system, soft tissue tumors, primary malignant 
bone tumors, and metastatic tumors. Consider breast cancer as an example: 
Phase 0 and I: Breast-conserving conservative surgery + postoperative radical 
radiotherapy or modified radical mastectomy. 
Early Phase II: Same as Phase 0 and I. Chemotherapy or endocrine therapy will 
be performed according to pathology and receptor conditions. 
Phase II: Modified radical mastectomy ± radiotherapy ± chemotherapy ± endo-
crine therapy. 
Phase III: Neoadjuvant chemotherapy ± radiotherapy + modified radical mastec-
tomy (or radical resection) ＋ postoperative radiotherapy ＋ chemotherapy ± en-
docrine therapy. 
Phase IV: Mainly chemotherapy and endocrine therapy ± local radiotherapy ± 
local operation. 
5. Diagnosis and treatment for cancer pain: Mechanism and classification of cancer 
pain, evaluation (conventional evaluation principle, quantitative evaluation prin-
ciple, comprehensive evaluation principle and dynamic evaluation principle) of 
cancer pain, and therapeutic principles and methods (etiological treatment, drug 
analgesia therapy and non-drug therapy) for cancer pain. 
6. Pharmacological action and pharmacokinetics of drugs. 
7. Drug options and doses, dose intensity, relative dose intensity, dose density, 
course of treatment, intervals, etc. 
Since new clinical knowledge cannot be applied automatically without clinical ver-
ification, a hierarchy expansion is implemented for incorporating new input data, 
which should be supported by clinical evidence and supervised by a knowledge engi-
neer. 
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4 Experiments and evaluation 
4.1 Example: Diagnosis, Prognosis and Treatment of Gastric Cancer 
The output interface of the DSS is mainly used to generate query results. Fig. 4-6 
illustrate the diagnosis, prognosis and treatment of gastric cancer. In Fig.4, SAT Δ 
concerns gastric cancer diagnosis. Its inference graph refers to the evolution of exist-
ing gastric cancer cases, corresponding to the structure of SAT Δ detailed in Fig. 2. In 
the inference graph, Δ0 indicates a positive diagnosis, Δ1 specifies a differential diag-
nosis, and Δ2 to Δ6 identify etiological diagnoses. The initial presence of gastric can-
cer (SO1) can lead to diagnoses Δ1 to Δ6 according to clinical signs SE1 to SE6. 
 
Figure 4 Clinical signs to determine gastric cancer 
SAT Θ indicates various therapeutic strategies (Θ1 to Θ6) (Fig.5) corresponding to 
different diagnoses and prognoses. The knowledge encapsulated in these several steps 
is stored in the DSS and can be extracted by CBR. 
 
Figure 5 Diagnoses and therapies for curing gastric cancer 
Fig.6 shows the similar clinical cases extracted by CBR. After the patient's condition 
is input into the DSS, the CBR base of object cases serves as a corpus to search for 
optimal treatments for a 40-year-old man with gastric cancer at the postoperative 
stage IIIa and pyloric obstruction. After separating the new clinical case and the cor-
⨅1
⨅6
⨅4⨅5
⨅2
⨅3
SE6
Recurrent cancer after treatment. Probably a localized recurrence 
(return to where it started), or may be a distant metastasis (back in 
another part of the body).
The tumor grows in the lamina propria, muscularis mucosa, or the 
submucosa (inner layers of the stomach wall).
The tumor grows through all the layers of muscle in the connective 
tissue outside the stomach and develops into the peritoneum or serous 
or organs surrounding the stomach.
The tumor grows in the muscularis (muscle layer of the stomach).
SE5
SE4
SE1
SE3
No evidence of lymph node metastases.
SO1
The tumor grows through all the layers of muscle in the connective 
tissue on the outside of the stomach, but not in the propagation of 
serous or peritoneal wall.
Table 1.1 Legend of clinical obligatory signs (SO), and evocative signs (SE)
∆0 ∆1
∆4.5∆6
∆2
SO1+SE1 SO1+¬ SE1
∆3
SO1+SE3
SO1+SE6
SO1+SE4∪ SE5
Table 1.2 diagnosis and prognosis of gastric 
cancer
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responding health record, CBR computes the similarities of related components by 
exploring the indexed knowledge. Matching approach is launched to carry out 
knowledge representation and similar clinical cases selection. CBR seeks to identify 
clinical cases with important words such as terminologies (e.g. syndrome: acid reflux, 
belching, vomiting…) and corresponding synonyms, as well as adjectives (e.g. upper 
abdominal discomfort, occasional postprandial pain…) and verbs (occur, accompany, 
cause…) that make phrase more accurate. 
 
Figure 6 Extraction of similar clinical cases with CBR 
In Fig.6, with the information of current patient such as Δ (gastric cancer stage IIIa) 
and PB (problem of current case: high-differentiated adenocarcinoma, pyloric ob-
struction, palpable mass, abnormal thickening of antral wall and mucosa…), DSS 
works with CBR to search and provide a list of clinical treatment suggestions to pa-
tients and physicians. 
Concerning the case of Fig.6 top panel (clinical case in need of help), one of the 
optimal clinical treatment suggestions (Fig.6 bottom panel) is detailed in this article 
with key elements: 
- 1st round Θ: underwent radical gastrectomy; 
2nd round Θ: laparotomy+retroperitoneal partial resection+abdominal tumor 
reduction surgery 
3rd round Θ: chemotherapy: CPT-11(120mg)+5-Fu(300mg); 
4th round Θ: nodular partial excision + side-by-side ascending-ilea colon. 
- 1st round SΘ: postoperatively adjuvant chemotherapy; 
2nd round SΘ: intraperitoneal chemotherapy with DDP 2; 
4th round SΘ: chemotherapy with DDP +5-FU. 
And R (result: death; survival time: 4 years 11 months), as well as some additional 
information like date and duration. Other extracted similar cases are not detailed for 
the sake of brevity. Physicians can therefore make clinical decisions by referencing to 
similar cases provided by DSS. 
8 
4.2 ROC Graphs for the Performance Evaluation 
Based on the positive and negative cases of gastric cancer, we compare the classifica-
tion effectiveness of the DSS with and without ontology.  
The 5-fold cross-validation method was used to randomly divide the experimental 
dataset into five sub-datasets of the same size. Each was used separately as the test set 
and the other four as the training set. These five experiments were repeated using the 
DSS with and without ontology, and the average precision of the classification results 
was calculated. In a binary classification, a sample is judged to belong to a certain 
class when its posterior probability of belonging to that class is greater than 0.5. The 
threshold was therefore set to 0.5 for the precision calculation. The results are pre-
sented in Table 1 and Table 2. As shown in these two tables, the average precision of 
the results increased by 11% (from 73.68% to 84.63%). 
Table 1. Experimental results on DSS without ontology 
No. of test samples TP FP TN FN FP / (FP + TN) TP/(TP+ FN) Accuracy 
78 39 17 20 2 0.46 0.95 75.64% 
77 38 17 18 3 0.48 0.93 72.72% 
77 37 15 19 6 0.44 0.86 72.72% 
76 37 16 18 5 0.47 0.88 72.36% 
76 37 15 20 4 0.43 0.90 75.00% 
Average Accuracy 73.68% 
Table 2. Experimental results on DSS with ontology 
No. of test samples TP FP TN FN FP / (FP + TN) TP/(TP+ FN) Accuracy 
78 43 10 23 2 0.30 0.95 84.61% 
77 43 7 24 3 0.22 0.94 87.01% 
77 42 11 22 2 0.33 0.95 83.11% 
76 44 8 21 3 0.27 0.94 85.52% 
76 41 12 22 1 0.35 0.97 82.89% 
Average Accuracy 84.63% 
On the basis of the above experimental results, ROC curves were used to evaluate the 
classification performance of the DSS with and without ontology (Fig. 7). The red and 
black curves represent the classification performance of DSS with and without ontol-
ogy, respectively. The diagonal navy gray line shows a random model. The curves 
climb quickly upward initially, indicating that the model correctly predicted the cases. 
Given the same test dataset, the classification performance of the DSS with ontology 
is significantly better than that of the DSS without ontology. Moreover, the AUC of 
the DSS with ontology is 0.846, which means that in 84.6% of cases, a randomly 
selected case from the group where the target equals 1 has a higher score than that of 
a randomly chosen case from the group where the target equals 0. This approach 
clearly outperforms the DSS without ontology, which achieved an AUC of only 73%. 
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Figure 7 ROC chart and AUC for classifier evaluations 
5 Conclusion 
This study has developed a DSS for diagnosing and treating cancers. To strengthen 
the knowledge and interlinking of data, our system is based on the reuse of an existing 
disease ontology, which improves the reasoning ability of the DSS. The patient’s 
condition is analyzed to estimate the stage of the cancer. Based on previous cases 
indexed in the CBR database, the search results will be returned to the doctors for use 
as references in diagnosis. 
In our future research, we will adopt the ontology enrichment method to reuse oth-
er existing biomedical ontologies, leading to a large domain ontology. In this case, 
several modules can be added to the DSS. For example, the treatment of cancer pa-
tients is conducted in cycles; therefore, a warning function shall be added to the sys-
tem to remind the medical staff to carry out a new cycle of treatment. When a thera-
peutic regimen is given by the system according the patient’s conditions, an introduc-
tion (including pharmaceuticals, price and major efficacy) to the recommended medi-
cations [19] will be presented below the window to help doctors use drugs rationally 
according to the patient’s financial situation. 
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